Overview
Paleo was founded in 2020 and is headquartered in Brussels. The company uses precision fermentation to produce heme proteins, the molecules responsible for the meat-like flavor and color in animal products, without the use of GMO organisms. These proteins are sold as ingredients to plant-based meat producers who want to improve the taste and appearance of their products.
The company raised a EUR 12M Series A. Paleo's GMO-free positioning addresses a key commercial barrier in European markets where consumer and regulatory sensitivity to GMOs is high, distinguishing it from some US-based precision fermentation competitors.
Funding & milestones
3 events found for Paleo · 2021–2026
SeedVenture / equity1 sourceEUR 2M
Reported amount EUR 2,000,000
Company announces EUR 2m seed capital for research and an R&D center.
Series AVenture / equity1 sourceEUR 12M
Reported amount EUR 12,000,000
Participating investor confirms completed EUR 12m Series A.
Funding eventType unspecified1 sourceAmount not disclosed
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Profile narrative
- EUR 12M Series A
Key people
In the news
- Foodleap cheer-out to Paleo! €2M raised to support the commercial scale-up of its animal-free heme proteins. Congratulations to the Paleo team! Paleo is a great example of how precision fermentation can help tackle one of the key challenges in the protein transition: creating alternatives that deliver on the taste, aroma, colour and nutrition consumers expect. Using yeast fermentation, Paleo produces animal-free, non-GMO myoglobins — proteins naturally found in animal muscle, with applications in plant-based alternatives to
- An interview with Anay Mridul from Green Queen on Paleo, myoglobin and what comes next for alternative proteins: https://lnkd.in/eyQDjkKY. An excerpt: “We therefore believe myoglobin can be a game-changer for the category and help manufacturers develop products capable of bringing consumers back.” And on the need to rethink how we approach the market: “The alternative protein market has changed significantly, and I don’t believe simply repeating the strategies of the past will be enough. We need to find more creative ways. We are
- It’s been a while since I posted here. We’ve been working below the radar on securing additional funding for Paleo — and I’m happy to share that we succeeded. Our priorities are clear: advance our regulatory submissions and deepen strategic collaborations with commercial partners. The alternative protein sector has been going through a difficult period for several years. Yet we remain convinced about Paleo’s future. Why? Because our product is strong. Very strong. Over the past two years, we have reduced production costs by a factor
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.